Etiqueta: research
-
Umbilical Cord Tissue Mesenchymal Stem Cells Best For Clinical Applications
A recent study concluded that umbilical cord tissue is the best source for clinically utilizable mesenchymal stem cells. Comparative Characterization of Cells from the Various Compartments of the Human Umbilical Cord Shows that the Wharton’s Jelly Compartment Provides the Best Source of Clinically Utilizable Mesenchymal Stem Cells. Arjunan Subramanian, Chui-Yee Fong, Arijit Biswas, Ariff Bongso…
-
Why Stem Cells Work: Clinical Trials for Spinal Cord Injury, Multiple Sclerosis, Rheumatoid Arthritis, and Duchenne’s Muscular Dystrophy
—
por
en Bone Marrow Stem Cells, Clinical Trials, Duchenne’s muscular dystrophy, Duchenne’s muscular dystrophy, Medistem Labs Panama, Mesenchymal Stem Cells, Multiple Sclerosis, Muscular Dystrophy, muscular dystrophy, Neil Riordan PA PhD, News, Rheumatoid Arthritis, Spinal Cord Injury, Stem Cell Lecture Videos, Stem Cell Research, Stem Cell Therapy, umbilical cord tissue stem cellsNeil Riordan, PhD speaks at the Riordan-McKenna Institute and Stem Cell Institute fall seminar in Southlake, Texas on October 10, 2015. Dr. Riordan discusses: How our lab selects uses specialized screening techniques to select only the stem cells that we know will be the most useful for our patients. Only about 1 in 100 cords…
-
After FDA Approval, Duchenne’s Muscular Dystrophy Patient Receives First Umbilical Cord Stem Cell Treatment in the United States
Ryan Benton, a 28 year-old Duchenne’s muscular dystrophy patient from Wichita, Kansas, received his first umbilical cord tissue-derived mesenchymal stem cell treatment yesterday at Asthma and Allergy Specialists of Wichita, KS following US FDA approval of his doctor’s application for a single patient, investigational new drug (IND) for compassionate use. Wichita, KS (PRWEB) September 10,…
-
The dual effect of MSCs on tumour growth and tumour angiogenesis
Michelle Kéramidas, Florence de Fraipont, Anastassia Karageorgis, Anaïck Moisan, Virginie Persoons, Marie-Jeanne Richard, Jean-Luc Coll and Claire Rome Abstract (provisional) Introduction Understanding the multiple biological functions played by human mesenchymal stem cells (hMSCs) as well as their development as therapeutics in regenerative medicine or in cancer treatment are major fields of research. Indeed, it has…
-
Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients
Cell Transplant. 2013 Feb 26. [Epub ahead of print] El-Kheir WA, Gabr H, Awad MR, Ghannam O, Barakat Y, Farghali HA, Maadawi ZM, Ewes I, Sabaawy HE. Abstract Spinal cord injuries (SCI) cause sensory loss and motor paralysis and are treated with physical therapy, but most patients fail to recover due to limited neural regeneration.…
-
Could Metabolic Syndrome, Lipodystrophy, and Aging Be Mesenchymal Stem Cell Exhaustion Syndromes?
Eduardo Mansilla,1,* Vanina Díaz Aquino,1 Daniel Zambón,2 Gustavo Horacio Marin,1 Karina Mártire,1 Gustavo Roque,1 Thomas Ichim,3 Neil H. Riordan,3 Amit Patel,4 Flavio Sturla,5 Gustavo Larsen,6, 7 Rubén Spretz,6, 7 Luis Núñez,8, 9 Carlos Soratti,10 Ricardo Ibar,10 Michiel van Leeuwen,11 José María Tau,1 Hugo Drago,5 and Alberto Maceira1 Abstract One of the most important and complex…
-
Multiple Sclerosis Treatment Success Using Mesenchymal Stem Cell-Secreted Factors in Animal Model
Stem cell researchers at Case Western Reserve have reported in Nature Magazine that the functional deficits caused by multiple sclerosis can be reduced by administering mesenchymal stem cell secreted factors. While previous studies have shown promising results using mesenchymal stem cells, this is the first time that such results have been reported without using the…
-
First patient to get stem cell therapy identified
By Rob Stein, The Washington Post Embryonic stem cells have numerous pitfalls in addition to the ethical dilemmas. While the concept of a “blank slate” cell is extremely attractive in terms of generating new tissues for transplantation and organ replacement, the problem is that these cells are so young that they do not properly “know”…